Our most-viewed stories in April included coverage of Amazon's new policy for dietary supplement sellers, Goli's acquisition, the beauty market, and more.
With a sizable portion of U.S. consumers taking new weight loss drugs, experts discussed ramifications for marketers, brands, and healthcare practitioners.
The latest of what will be several guidance documents on the NDI process provides updates on the agency’s proposed method to handle proprietary information.